Cooling During Exercise in the Heat

Sponsor
University of Manitoba (Other)
Overall Status
Recruiting
CT.gov ID
NCT05890261
Collaborator
(none)
8
1
1
11.5
0.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the effectiveness of upper-body surface cooling with whole-body surface cooling on exercise performance while wearing firefighter clothing in the heat. The main question it aims to answer is:

• which cooling protocol best prevents an increase in core temperature during exercise in the heat?

Participants will be asked to participate three times in a 60-minute exposure (to 40 degrees C, 40% relative humidity) in which they conduct three work/rest periods including 15 minutes of stepping exercise (20 steps/minute) and 5 minutes of rest. The following three conditions will include:

  • Control: no cooling garments

  • Upper-body cooling: cold water-perfused cooling vest

  • Whole-body cooling: cold water-perfused cooling pants and cooling vest

Condition or Disease Intervention/Treatment Phase
  • Device: Cold water-perfused cooling garment
N/A

Detailed Description

The objectives are to determine thermoregulatory stress (e.g., change in skin and core temperature), physiologic stress (e.g., heart rate and metabolism), cognitive function (Mini-Cog; includes clock drawing and three-word recall), and subjective responses (e.g., thermal comfort, heat sensation, rating of perceived exertion, subjective wetness, breathing comfort) during three conditions while exercising in the heat while wearing thermal protective clothing. The conditions are control (no cooling), upper-body cooling, and whole-body cooling.

Physiologic measures:

Core temperature. Core temperature (°C) will be monitored with e-Celsius, an ingestible pill that continuously monitors, records, and wirelessly transmits core temperature.

Skin temperature. Mean skin temperature (ºC) will be measured with small metal discs (iButton, EDS) taped to the skin at the following 7 sites: forehead, chest, abdomen, upper arm, lower arm, anterior thigh, and anterior calf.

Heart rate and respiration. A Hexoskin shirt will be worn. Sensors in the shirt measure heart rate and chest expansion for breathing indicators.

Metabolism. Subjects will wear a face mask and oxygen consumption, VCO2 and minute ventilation is going to be continuously monitored with a metabolic cart.

Sweat loss. Will be determined from differences in body and clothing weight measured before and after the exercise trials.

Subjective measures:

Every 20 minutes during the exercise test (see below), participants will be asked to rate the following: thermal comfort, heat sensation, rating of perceived exertion (RPE), breathing comfort, and skin wetness.

This will be followed by a test of cognitive function. This involves two components: a three-item recall test and a clock-drawing task. Investigators will ask the subject to repeat three unrelated words (e.g., apple, table, penny) and then will ask them to recall those words after a few minutes. While the subject is trying to recall the words, investigators will ask them to draw a clock face including all of the numbers, and the hands showing a specific time (e.g., 10 minutes past 11). Then the subjects will then be asked to repeat the original 3 words in order.

Cooling procedures:

Cooling will be applied through a liquid-perfused shirt and pants. Each garment has small tubes sewn into the interior of the garment. Cold water (3-8 degrees C) will be perfused through the garments at 5 l/min. The garments will be worn over the Hexoskin shirt and shorts.

Exercise test:

This 60-minute test involves 3 sets of 15 minutes of stepping exercises (20 steps per minute) followed by 5 minutes of sitting rest. During the rest periods, They will be asked to give their subjective evaluations of thermal comfort, heat sensation, rating of perceived exertion, breathing comfort, skin wetness, and cognitive function.

The exercise test will be stopped and the subject will exit the chamber if: the core temperature reaches 39 degrees C; the subject feels light-headed, or nausea; the subject indicates a wish to stop for any reason; or a researcher feels the subject should stop for any reason.

Protocol:

Once subjects have been instrumented they will sit for 10 minutes of baseline measurements in the laboratory (~20 degrees C). They will then enter a climatic chamber (40 degrees C, 40% humidity) and complete the 60-minute exercise/rest protocol. They will then exit the chamber and sit for another 10 minutes of post-exercise measurements.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Repeated measures designRepeated measures design
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Cooling During Exercise in the Heat
Actual Study Start Date :
May 15, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Young healthy subjects

Young healthy subjects

Device: Cold water-perfused cooling garment
Two types of cooling garments will be used. One is a cooling vest and the other includes cooling pants.

Outcome Measures

Primary Outcome Measures

  1. Change in Core temperature [Times 0, 30, 50, 70 and 85 min]

    Core temperature will be measured with a radio pill that is ingested 2 hours pre-trial.

Secondary Outcome Measures

  1. Change in Mental performance [Times 0, 30, 50, 70 and 85 min]

    Mini-Cog test for recall and cognition

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18-49 years.

  • Meet the criteria on the CSEP Get Active Questionnaire

  • Answer 'no' to questions in the Screening Questionnaire.

Exclusion Criteria:
  • Outside the accepted age bracket.

  • Not meeting the criteria on the CSEP Get Active Questionnaire or the Screening Questionnaire.

Contacts and Locations

Locations

Site City State Country Postal Code
1 211 Max Bell Centre, University of Manitoba Winnipeg Manitoba Canada R3T 2N2

Sponsors and Collaborators

  • University of Manitoba

Investigators

  • Principal Investigator: Gordon Giesbrecht, PhD, University of Manitoba

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Manitoba
ClinicalTrials.gov Identifier:
NCT05890261
Other Study ID Numbers:
  • HE2023-0101
First Posted:
Jun 6, 2023
Last Update Posted:
Jun 6, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Manitoba

Study Results

No Results Posted as of Jun 6, 2023